Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update

Basit Öğe Kaydı
dc.contributor.authorSaydam, Guray
dc.contributor.authorHaznedaroglu, Ibrahim Celalettin
dc.contributor.authorKaynar, Leylagul
dc.contributor.authorYavuz, Akif S.
dc.contributor.authorAli, Ridvan
dc.contributor.authorGuvenc, Birol
dc.contributor.authorAkay, Olga M.
dc.date.accessioned2024-04-24T17:50:01Z
dc.date.available2024-04-24T17:50:01Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.issue21en_US
dc.identifier.urihttps://hdl.handle.net/11468/23166
dc.identifier.volume124en_US
dc.identifier.wosWOS:000349242701217
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Soc Hematologyen_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleNilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Updateen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu